Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10. Am J Physiol Gastrointest Liver Physiol 291: G91-G94, 2006; doi:10.1152/ajpgi.00095.2004.-Biliary obstruction in the setting of hepatic bacterial infection has great morbidity and mortality. We developed a novel murine model to examine the effect of biliary obstruction on the clearance of hepatic Escherichia coli infection. This model may allow us to test the hypothesis that biliary obstruction itself adversely affects clearance of hepatic infections even if the bacteria are introduced into the liver by a nonbiliary route. We ligated the bile ducts of C57BL/6 mice on days Ϫ1, 0, or ϩ1, relative to a day 0 portal venous injection of E. coli. We monitored survival, hepatic bacterial growth, pathology, and IL-10 protein levels. The role of IL-10 in this model was further examined using IL-10 knockout mice. Mice with bile duct ligation at day ϩ1 or 0, relative to portal venous infection at day 0, had decreased survival compared with mice with only portal venous infection. The impaired survival was associated with greater hepatic bacterial growth, hepatic necrosis, and increased production of IL-10. Interestingly, the transgenic knockout of IL-10 resulted in impaired survival in mice with bile duct ligation and portal venous infection. Biliary obstruction had a dramatic detrimental effect on hepatic clearance of portal venous E. coli infection. This impaired clearance is associated with increased IL-10 production. However, transgenic knockout of IL-10 increased mortality after hepatic infection. biliary; biliary; cholangitis; liver; Escherichia coli PATIENTS WITH CHOLANGITIS are sicker than patients infected with the same bacteria in other locations (6, 9, 13, 17, 24) . To understand why these patients are so ill, one must consider the two components of cholangitis: hepatic infection and bile duct obstruction (13). Infection may result from bacteria entering the liver from the gastrointestinal tract via a number of different routes. These include the portal vein (PV), the lymphatic drainage of the gut (18, 19) , and the biliary tract (9, 24). Bile duct obstruction may contribute to cholangitis by altering hepatic inflammation and cytokine production. Evidence for the latter is the hepatic inflammatory response to bile duct obstruction in the absence of infection. This includes a neutrophilic infiltrate (20) and the production of cytokines (2-5, 12, 16, 23).
PATIENTS WITH CHOLANGITIS are sicker than patients infected with the same bacteria in other locations (6, 9, 13, 17, 24) . To understand why these patients are so ill, one must consider the two components of cholangitis: hepatic infection and bile duct obstruction (13) . Infection may result from bacteria entering the liver from the gastrointestinal tract via a number of different routes. These include the portal vein (PV), the lymphatic drainage of the gut (18, 19) , and the biliary tract (9, 24) . Bile duct obstruction may contribute to cholangitis by altering hepatic inflammation and cytokine production. Evidence for the latter is the hepatic inflammatory response to bile duct obstruction in the absence of infection. This includes a neutrophilic infiltrate (20) and the production of cytokines (2-5, 12, 16, 23) .
In this manuscript, we assess the effect of biliary obstruction itself on hepatic infection after PV infections of E. coli, a clinically relevant pathogen. We studied hepatic bacterial growth, pathology, and production of IL-10.
MATERIALS AND METHODS
Animals. Six-to eight-week-old male wild-type C57BL/6 and IL-10 knockout B6.129IL10 tm1Cgn /J (1) mice were obtained from Jackson Laboratories (Bar Harbor, ME). The mice were handled and housed according to National Institutes of Health and institutional guidelines, and the study was approved by the Institutional Animal Care and Use Committee.
Bile duct ligation. Mice were anesthetized using inhaled isofluorane. The midline laparotomy was performed under sterile conditions. Bile duct ligation (BDL) was performed by dissecting the common bile duct (CBD) below the entrance of the cystic duct. Care was taken to stay above the level of the entrance of the pancreatic duct to avoid ligation of the pancreatic duct and pancreatitis. Lack of pancreatitis was confirmed by measuring serum amylase levels. The CBD was ligated at this level using 6 -0 silk suture. BDL was performed at day Ϫ1, 0, or ϩ1 in relationship to PV injection with E. coli; see PV injection. The animals were closed in two layers using 6 -0 silk suture.
PV injection. The PV was isolated by reflecting intestinal contents to the left of the animal. Initial experiments were performed using PV methylene blue injections and demonstrated hepatic, but not splenic or mesenteric, perfusion of blue. Free-hand injection of E. coli, LPS, or saline was performed using a 0.25-ml volume and 30-gauge needle. Hemostasis was achieved by direct compression. The day of PV injection was defined as day 0.
Bacteria growth and preparation. E. coli (ATCC #25922; known to be pathogenic in rodents) was grown in broth overnight. Turbidity was measured, and dilutions were prepared from previously delineated growth curves. The number of viable bacteria, which were injected, was confirmed by plating the innoculum on soy agar plates and determining the colony-forming units (cfu).
Survival studies. Animals were injected with E. coli into the PV as outlined above. BDL was performed at days Ϫ1, 0, and ϩ1, and PV injection performed at day 0. These groups were designated BDLϪ1/ PV0, BDL0/PV0, and BDLϩ1/PV0. Animals were followed for survival. Control animals were injected with saline solution. All further experiments were performed with the BDL0/PV0 protocol.
Bacterial growth in infected livers. To study the kinetics of bacterial growth, the left lobe of the liver was harvested at 4 and 24 h after PV injection of 5 ϫ 10 4 E. coli (BDL0/PV0). The liver was homogenized and plated on soy agar plates (Remel, Lenexa, KS) and the colony-forming units recovered were counted after overnight incubation. The total colony-forming units recovered from each liver were calculated. The animals that were injected with saline in the presence or absence of BDL were used as controls to ensure sterility.
Histology. Liver tissues from animals receiving 5 ϫ 10 4 cfu E. coli into the PV in the absence or presence of BDL were harvested 24 h after injection, placed in formalin, and subjected to standard hematoxylin and eosin staining. Slides were examined with the assistance of an experienced hepatopathologist.
Cytokine protein. Serum was obtained by retroorbital bleeding from animals that had been injected with 5 ϫ 10 4 cfu E. coli into the PV in the presence of BDL (BDL0/PV0) 24 h before. IL-10 protein levels were measured by ELISA (Endogen).
Infection of transgenic knockout mice.
To examine the role of IL-10 production in our model, 6-wk-old B6.129IL10 tm1Cgn /J mice, deficient in IL-10, were injected with 5 ϫ 10 4 cfu E. coli into the PV with concurrent BDL (ϩBDL). To assess whether there was a baseline alteration in the IL-10 knockout mouse's ability to handle E. coli even in the absence of BDL, another group of IL-10 knockout animals were subjected to PV injection of 5 ϫ 10 4 cfu E. coli without BDL (ϪBDL). Survival was monitored. Six-week-old C57BL/6J mice were used as controls.
Statistical analysis. Log-rank test was used to assess significance for survival experiments. Student's t-test was used to assess differences in cytokine production. Figure 1 is representative of three experiments and demonstrates that BDL exacerbated PV E. coli infection. All mice received a PV injection of E. coli on day 0 (D0PV). In addition, control mice had sham surgery on day Ϫ1, 0, or ϩ1 relative to the E. coli injection; hepatic bacterial growth in all of these mice was similar, and they are shown as a single group designated as sham/PV. In addition to PV E. coli injections, experimental mice also had BDL on day Ϫ1 (D-1 BDL/D0PV), day 0 (D0 BDL/D0PV), or day ϩ1 (Dϩ1 BDL/D0PV) relative to these injections. The only deaths occurred in animals with both PV E. coli and BDL. Among the BDL mice, the greatest mortality occurred when the bile ducts were either ligated on the day of PV E. coli injection (D0BDL/D0PV) or ligated the day after injection (D0BDL/Dϩ1PV). In the remainder of this manuscript, the focus is on the D0BDL/D0PV group. Figure 2 demonstrates that BDL impairs hepatic clearance of PV E. coli injections. The initial cfu of hepatic E. coli were similar in animals that had or had not received BDL. This result confirms equivalent initial delivery of pathogen to the liver. However, by 24 h postinfection, significantly greater cfu were recovered in animals that had BDL compared with those that had no BDL. To confirm that the E. coli recovered from the infected livers was derived from those injected, we compared the antibiotic sensitivities of the initial innoculum and the E. coli recovered at 24 h. All E. coli were resistant to ampicillin and chloramphenicol but sensitive to penicillin.
RESULTS

BDL impairs survival after PV E. coli infection.
BDL results in greater histological injury after PV infection. Histology confirmed increased hepatic injury when PV infections occurred in the presence of BDL compared with infection in the absence of BDL. Figure 3 shows the massive geographic necrosis and exuberant sinusoidal bacterial growth in the livers that were infected in the presence of BDL. There was much less infection and injury in the livers that were infected in the absence of BDL. Figure  4 demonstrates that IL-10 serum levels were significantly increased in animals that had BDL compared with those that had none at the time of PV injection with bacteria. Lower levels of IL-10 were found in animals that received PV saline, instead of E. coli, in the presence or absence of BDL. Unmanipulated animals had levels of IL-10 that were Ͻ200 pg/ml.
BDL and PV E. coli infection increased serum IL-10.
Transgenic knockout of IL-10 increased late mortality after PV infection plus BDL.
The previous data show that BDL exacerbates hepatic infection after PV injections of E. coli. The increased serum levels of IL-10 in infected mice with BDL compared with the sham-operated infected mice suggested a role for this cytokine because of its known immunosuppressive effects. To test this idea, we compared PV infections in wild-type vs. IL-10 knockout mice in the experiment shown in Fig. 5 . We found that, in contrast to our expectation, IL-10 knockout increased late mortality after PV injection of E. coli plus BDL.
Note that transgenic knockout of IL-10 resulted in late death of mice (days [3] [4] [5] . In contrast, death in wild-type mice typically occurred at days 1-3 (see Figs. 1 and 5 ). This result suggests that the presence of IL-10 in the late phase of infection was beneficial. Consistent with this idea, Fig. 6 shows a trend to increased hepatic bacterial growth in the transgenic knockout animals.
To rule out an abnormal response to PV injection in the IL-10 knockout mouse, we injected the PV of these mice with saline instead of E. coli. The mice displayed no symptoms and survived for Ͼ10 days. 
. Bile duct ligation (BDL) impairs survival after portal venous (PV)
Eschericia coli infection. Six-to eight-week-old C57BL/6 mice received a PV injection of 5 ϫ 10 4 colony-forming units (cfu) E. coli on day 0 (D0PV); in addition, each of these injected mice also had a sham operation or BDL at days Ϫ1 (DϪ1 BDL/D0PV), 0 (D0BDL/D0PV), or ϩ1 (Dϩ1BDL/D0PV). Survival was monitored (n ϭ 7/group). Fig. 2 . BDL impairs hepatic clearance of PV E. coli injections. Six-to eight-week-old C57BL/6 mice received PV E. coli (5 ϫ 10 4 cfu) and, at the same time, also had either sham surgery or BDL. The left lobe of the liver was harvested and cultured at either 4 or 24 h after infection, as outlined in MATERIALS AND METHODS. Significantly greater E. coli were recovered from the BDL group at 24 h after infection (n ϭ 4 animals per group; P Ͻ 0.05 by t-test).
DISCUSSION
Our data show that BDL dramatically increases the mortality of hepatic infections introduced via the PV (Fig. 1) , increases hepatic bacterial growth (Fig. 2) , and increases hepatic pathol- ogy (Fig. 3 ). This murine model may be important because patients with bile duct obstruction and concurrent gram-negative hepatic infections have a high mortality (6, 9, 13, 17, 24) .
Our data are consistent with the hypothesis that biliary obstruction itself impairs the hepatic response to infections. One possibility is that biliary obstruction alters the hepatic inflammatory response (2, 3, 5, 10, 12, 16, 20, 22, 23) . Some published observations are consistent with the possibility that biliary obstruction increases the production of anti-inflammatory heme oxygenase 1 that ameliorates myoglobinuric acute renal failure (11) and increases the production of IL-10 that ameliorates ischemic acute renal failure (10) .
Because of the known immunosuppressive effects of IL-10, we investigated its production in our model. We found increased IL-10 in mice with PV infection plus BDL compared with mice with PV infection without BDL (Fig. 4) . However, transgenic knockout of IL-10 impairs survival after BDL and PV infection (Fig. 5 ). In addition, there was a trend toward increased bacterial growth in the transgenic knockout mice (Fig. 6) .
Our results illustrate the complex roles of IL-10 in infection. In some situations, IL-10 may inhibit inflammation, decrease host defenses, and thus increase mortality (8) . In other situations, IL-10 may prevent "collateral" damage by excessive inflammation (14) . Furthermore, IL-10 also may have proinflammatory functions (7). Our results are similar to previous data showing increased mortality in transgenic IL-10 knockout mice after E. coli peritonitis except that we did not find increased bacterial clearance in these mice (15, 21) .
In summary, we have established a model of murine hepatic infection and shown that BDL has a dramatic detrimental effect on PV E. coli infection as assessed by mortality, hepatic bacterial growth, and pathology. Although the BDL mice increased their production of IL-10, this does not account for the detrimental effect of BDL.
